| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100427B002 |
1.76 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100427B005 |
1.22 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100427B009 |
1.25 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100427B013 |
0.76 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100427B017 |
1.36 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100427B021 |
1.09 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100427B025 |
1.31 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100427B029 |
2.45 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100427B001 |
1.39 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100427B003 |
1 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100427B007 |
1.02 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100427B011 |
0.77 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100427B015 |
1.48 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100427B019 |
1.06 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100427B023 |
1.3 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100427B027 |
1.51 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100427B006 |
1.01 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100427B010 |
1.41 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100427B014 |
1.2 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100427B018 |
1.29 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100427B022 |
1.53 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100427B026 |
1.38 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100427B030 |
1.5 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100427B004 |
1.42 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100427B008 |
1.16 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100427B012 |
0.55 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100427B016 |
0.88 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100427B020 |
0.89 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100427B024 |
0.89 |
pmol/ug DNA |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100427B028 |
1.35 |
pmol/ug DNA |